The online version of this article (https://doi.org/10.1186/s12931-017-0701-z) contains supplementary material, which is available to authorized users.
Accumulation mode particles (AMP) are formed from engine combustion and make up the inhalable vapour cloud of ambient particulate matter pollution. Their small size facilitates dispersal and subsequent exposure far from their original source, as well as the ability to penetrate alveolar spaces and capillary walls of the lung when inhaled. A significant immuno-stimulatory component of AMP is lipopolysaccharide (LPS), a product of Gram negative bacteria breakdown. As LPS is implicated in the onset and exacerbation of asthma, the presence or absence of LPS in ambient particulate matter (PM) may explain the onset of asthmatic exacerbations to PM exposure.
This study aimed to delineate the effects of LPS and AMP on airway inflammation, and potential contribution to airways disease by measuring airway inflammatory responses induced via activation of the LPS cellular receptor, Toll-like receptor 4 (TLR-4).
The effects of nebulized AMP, LPS and AMP administered with LPS on lung function, cellular inflammatory infiltrate and cytokine responses were compared between wildtype mice and mice not expressing TLR-4.
The presence of LPS administered with AMP appeared to drive elevated airway resistance and sensitivity via TLR-4. Augmented TLR4 driven eosinophilia and greater TNF-α responses observed in AMP-LPS treated mice independent of TLR-4 expression, suggests activation of allergic responses by TLR4 and non-TLR4 pathways larger than those induced by LPS administered alone. Treatment with AMP induced macrophage recruitment independent of TLR-4 expression.
These findings suggest AMP-LPS as a stronger stimulus for allergic inflammation in the airways then LPS alone.
Additional file 1: Figure S1. Airway resistance in TLR4−/− mice treated with double distilled water (ddH2O) and saline. Saline responses were significantly greater for methacholine challenges larger than 3 mg/ml (* p < 0.05). (TIFF 356 kb)12931_2017_701_MOESM1_ESM.tif
Additional file 2: Figure S2. Airway resistance in wildtype (WT) and TLR4−/− mice for all treatment groups across for all methacholine challenges used. Raw was significantly greater in WT mice treated with LPS and AMP-LPS compared to control mice at 30 mg/ml MCh (*p < 0.05). (TIFF 1196 kb)12931_2017_701_MOESM2_ESM.tif
Additional file 3: Figure S3. Additional cytokines measured in bronchoalveolar lavage (BAL) and lung parenchyma. MCP-1 was measured in BAL using cytokine bead array assay (20-5000 pg/ml detection range) and IL-8 in lung parenchyma using ELISA (15.6-1000 pg/ml detection range) using optimised sample dilution factors. No significant difference with treatment was observed for these cytokines. (TIFF 558 kb)12931_2017_701_MOESM3_ESM.tif
Environmental Protection Agency U. National Ambient air Quality Standards for particulate matter; final rule, vol. 78. Research Triangle Park: National Archives and Records Administration: Federal Register; 2013. p. 103.
Yeatts K, Svendsen E, Creason J, Alexis N, Herbst M, Scott J, Kupper L, Williams R, Neas L, Cascio W, et al. Coarse particulate matter (PM2.5-10) affects heart rate variability, blood lipids, and circulating eosinophils in adults with asthma. Environ Health Perspect. 2007;115:709–14. CrossRefPubMedPubMedCentral
Lippmann M, Chen LC, Gordon T, Ito K, Thurston GD. National particle component toxicity (NPACT) initiative: integrated epidemiologic and toxicologic studies of the health effects of particulate matter components. Res Rep Health Eff Inst. 2013;177:5–13.
HEI Review Panel on Ultrafine Particles. Understanding the health effects of ambient ultrafine particles. In: HEI perspectives, vol. 3. Boston: Health Effects Institute; 2013. p. 122.
HEI Review Panel on Ultrafine Particles. Understanding the health effects of ambient ultrafine particles. In: HEI perspectives, vol. 3. Boston: Health Effects Institute; 2013. p. 102.
Hirota JA, Hirota SA, Warner SM, Stefanowicz D, Shaheen F, Beck PL, Macdonald JA, Hackett TL, Sin DD, Van Eeden S, Knight DA. The airway epithelium nucleotide-binding domain and leucine-rich repeat protein 3 inflammasome is activated by urban particulate matter. J Allergy Clin Immunol. 2012;129:1116–25. e1116 CrossRefPubMed
Happo MS, Salonen RO, Halinen AI, Jalava PI, Pennanen AS, Dormans JA, Gerlofs-Nijland ME, Cassee FR, Kosma VM, Sillanpaa M, et al. Inflammation and tissue damage in mouse lung by single and repeated dosing of urban air coarse and fine particles collected from six European cities. Inhal Toxicol. 2010;22:402–16. CrossRefPubMed
Wilson MS, Elnekave E, Mentink-Kane MM, Hodges MG, Pesce JT, Ramalingam TR, Thompson RW, Kamanaka M, Flavell RA, Keane-Myers A, et al. IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J Clin Invest. 2007;117:2941–51. CrossRefPubMedPubMedCentral
Lee CG, Homer RJ, Cohn L, Link H, Jung S, Craft JE, Graham BS, Johnson TR, Elias JA. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J Biol Chem. 2002;277:35466–74. CrossRefPubMed
- Accumulation mode particles and LPS exposure induce TLR-4 dependent and independent inflammatory responses in the lung
Angela M. Fonceca
Graeme R. Zosky
Elizabeth M. Bozanich
Erika N. Sutanto
Paul S. McNamara
Darryl A. Knight
Peter D. Sly
Debra J. Turner
Stephen M. Stick
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II